Literature DB >> 2539216

Prevention of diabetic nephropathy with enalapril.

M Marre, P Passa, G Chatellier, J Menard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539216      PMCID: PMC1835671          DOI: 10.1136/bmj.298.6671.459-c

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Management of diabetic renal involvement and disease.

Authors:  C E Mogensen
Journal:  Lancet       Date:  1988-04-16       Impact factor: 79.321

2.  Prevention of diabetic nephropathy with enalapril.

Authors:  S Pickering; M Sampson; W Foyle; P Drury
Journal:  BMJ       Date:  1988-12-17

3.  Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria.

Authors:  M Marre; H Leblanc; L Suarez; T T Guyenne; J Ménard; P Passa
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-06

4.  Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.

Authors:  R Zatz; B R Dunn; T W Meyer; S Anderson; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

5.  Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.

Authors:  M Marre; G Chatellier; H Leblanc; T T Guyene; J Menard; P Passa
Journal:  BMJ       Date:  1988-10-29

6.  Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Deckert
Journal:  Lancet       Date:  1986-12-06       Impact factor: 79.321

  6 in total
  1 in total

1.  Patient-level estimates of the cost of complications in diabetes in a managed-care population.

Authors:  S D Ramsey; K Newton; D Blough; D K McCulloch; N Sandhu; E H Wagner
Journal:  Pharmacoeconomics       Date:  1999-09       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.